Metraipolis › archive › dc_c5a52bb200dc

Safety and Efficacy of Orally Administered SJP-0008 in Central Retinal Artery Occlusion: A Phase IIa Randomized Clinical Trial — Europe PMC PMID:41321845

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41321845
DOI
10.1016/j.xops.2025.100965
License (as archived)
solo-consultazione
Archived
2026-11-09T10:04:24.150Z
SHA-256 of the archived text
43df116d8a1c06bdf2e22129356fcbf9763b9c15c599cecfb769a644c8baf068
Stable URL of this page
https://metraipolis.com/documento/dc_c5a52bb200dc

How to cite

Safety and Efficacy of Orally Administered SJP-0008 in Central Retinal Artery Occlusion: A Phase IIa Randomized Clinical Trial — Europe PMC PMID:41321845 — Europe PMC (en), https://europepmc.org/article/MED/41321845 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c5a52bb200dc (Metraipolis archive dc_c5a52bb200dc, sha256 43df116d8a1c06bdf2e22129356fcbf9763b9c15c599cecfb769a644c8baf068)
BibTeX
@misc{dcc5a52bb200dc,
  title = {Safety and Efficacy of Orally Administered SJP-0008 in Central Retinal Artery Occlusion: A Phase IIa Randomized Clinical Trial — Europe PMC PMID:41321845},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41321845},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c5a52bb200dc; sha256 43df116d8a1c06bdf2e22129356fcbf9763b9c15c599cecfb769a644c8baf068},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41321845. Agents can read the archived copy with the MCP tool read_document.